PIONEERING USE OF THE CLOUD FOR DEVELOPMENT OF COLLABORATIVE DRUG DISCOVERY ( CDD ) DATABASE - Collaborative Computational Technologies for Biomedical Research - page 359

30. Aronov AM , Balakin KV , Kiselyov A , Varma - O ' Brien S , Ekins S . Applications of
QSAR methods to ion channels . In Ekins S , Ed. Computational Toxicology: Risk
Assessment for Pharmaceutical and Environmental Chemicals . Hoboken, NJ : J
Wiley , 2007 , pp. 353 - 389 .
31. Ekins S , Balakin KV , Savchuk N , Ivanenkov Y . Insights for human ether - a - go - go -
related gene potassium channel inhibition using recursive partitioning, Kohonen
and Sammon mapping techniques. J Med Chem 2006 ; 49 : 5059 - 5071 .
32. Crumb Jr WJ , et al. Effects of antipsychotic drugs on I to , I Na , I sus , I K1 , and hERG: QT
prolongation, structure activity relationship, and network analysis. Pharm Res
2006 ; 23 : 1133 - 1143 .
33. Chouteau F , Ramanitrahasimbola D , Rasoanaivo P , Chibale K . Exploiting a basic
chemosensitizing pharmacophore hypothesis. Part 1: Synthesis and biological eval-
uation of novel arylbromide and bicyclic chemosensitizers against drug-resistant
malaria parasites. Bioorg Med Chem Lett 2005 ; 15 : 3024 - 3028 .
34. Chiyanzu I , Clarkson C , Smith PJ , Lehman J , Gut J , Rosenthal PJ . Design, synthesis
and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives.
Bioorg Med Chem 2005 ; 13 : 3249 - 3261 .
35. Weisman JL , Liou AP , Shelat AA , Cohen FE , Guy RK , DeRisi JL . Searching for
new antimalarial therapeutics amongst known drugs. Chem Biol Drug Design
2006 ; 67 : 409 - 416 .
36. Gold B , Deng H , Bryk R , Vargas D , Eliezer D , Roberts J , et al. Identifi cation of a
copper-binding metallothionein in pathogenic mycobacteria. Nat Chem Biol
2008 ; 4 : 609 - 616 .
37. Ribeiro I , Sevcsik AM , Alves F , Diap G , Don R , Harhay MO , et al. New, improved
treatments for Chagas disease: From the R&D pipeline to the patients. PLoS
Neglected Tropical Dis 2009 ; 3 : e484 .
38. Shukla AK , Singh BK , Patra S , Dubey VK . Rational approaches for drug designing
against leishmaniasis. Appl Biochem Biotechnol 2010 ; 160 : 2208 - 2218 .
39. Nussbaum K , Honek J , Cadmus CM , Efferth T . Trypanosomatid parasites causing
neglected diseases. Curr Med Chem 2010 ; 17 : 1594 - 1617 .
40. Zhang Y . The magic bullets and tuberculosis drug targets . Annu Rev Pharmacol
Toxicol 2005 ; 45 : 529 - 564 .
41. Balganesh TS , Alzari PM , Cole ST . Rising standards for tuberculosis drug develop-
ment . Trends Pharmacol Sci 2008 ; 29 : 576 - 581 .
42. Payne DA , Gwynn MN , Holmes DJ , Pompliano DL . Drugs for bad bugs: Confronting
the challenges of antibacterial discovery. Nat Rev Drug Disc 2007 ; 6 : 29 - 40 .
43. Ekins S , Bradford J , Dole K , Spektor A , Gregory K , Blondeau D . A collaborative
database and computational models for tuberculosis drug discovery. Mol BioSyst
2010 ; 6 : 840 - 851 .
44. Makarov V , Manina G , Mikusova K , Mollmann U , Ryabova O , Saint - Joanis B .
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.
Science 2009 ; 324 : 801 - 804 .
45. Ekins S , Kaneko T , Lipinksi CA , Bradford J , Dole K , Spektor A . Analysis and hit
fi ltering of a very large library of compounds screened against Mycobacterium
tuberculosis . Mol BioSyst 2010 ; 6 : 2316 - 2324 .
46. Ekins S , Williams AJ . Meta - analysis of molecular property patterns and fi ltering of
public datasets of antimalarial “ hits ” and drugs . MedChemComm 2010 ; 1 : 325 - 330 .